0001209191-18-063664.txt : 20181220 0001209191-18-063664.hdr.sgml : 20181220 20181220162534 ACCESSION NUMBER: 0001209191-18-063664 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181218 FILED AS OF DATE: 20181220 DATE AS OF CHANGE: 20181220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rivera Jose E CENTRAL INDEX KEY: 0001671870 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37766 FILM NUMBER: 181246474 MAIL ADDRESS: STREET 1: INTELLIA THERAPEUTICS, INC. STREET 2: 130 BROOKLINE STREET, SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intellia Therapeutics, Inc. CENTRAL INDEX KEY: 0001652130 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 364785571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-285-6200 MAIL ADDRESS: STREET 1: 40 ERIE STREET STREET 2: SUITE 130 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-18 0 0001652130 Intellia Therapeutics, Inc. NTLA 0001671870 Rivera Jose E C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130 CAMBRIDGE MA 02139 0 1 0 0 EVP, General Counsel Stock Option (right to buy) 14.58 2018-12-18 4 A 0 71000 0.00 A 2028-12-17 Common Stock 71000 71000 D This option was granted on December 18, 2018 with respect to 71,000 shares of Common Stock, with 25% vesting on December 18, 2019 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter. /s/Jose Rivera 2018-12-20